Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

Open access
López-Lacort, Mónica, Muñoz-Quiles, Cintia, Mira-Iglesias, Ainara, López-Labrador, F Xavier, Mengual-Chuliá, Beatriz, Fernández-García, Carlos, Carballido-Fernández, Mario, Pineda-Caplliure, Ana, Mollar-Maseres, Juan, Shalabi Benavent, Maruan, Sanz-Herrero, Francisco, Zornoza-Moreno, Matilde, Pérez-Martín, Jaime Jesús, Alfayate-Miguelez, Santiago, Pérez Crespo, Rocío, Bastida Sánchez, Encarnación, Menasalvas-Ruiz, Ana Isabel, Téllez-González, Mª Cinta, Esquiva Soto, Samuel, Del Toro Saravia, Carlos, Sanz-Muñoz, Iván, Eiros, José María, Matías Del Pozo, Vanesa, Toquero-Asensi, Marina, Pastor-Villalba, Eliseo, Lluch-Rodrigo, José Antonio, Díez-Domingo, Javier, Orrico-Sánchez, Alejandro · 2024 · Eurosurveillance

Abstract

The monoclonal antibody nirsevimab was at least 70% effective in preventing hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory syncytial virus (RSV) in Spain (Oct 2023–Jan 2024), where a universal immunisation programme began late September (coverage range: 79–99%). High protection was confirmed by two methodological designs (screening and test-negative) in a multicentre active surveillance in nine hospitals in three regions. No protection against RSV-negative LRTI-hospitalisations was shown. These interim results could guide public-health decision-making.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2807/1560-7917.es.2024.29.6.2400046

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 194

Metadata

Authors
López-Lacort, M., Muñoz-Quiles, C., Mira-Iglesias, A., López-Labrador, F. X., Mengual-Chuliá, B., Fernández-García, C., Carballido-Fernández, M., Pineda-Caplliure, A., Mollar-Maseres, J., Shalabi Benavent, M., Sanz-Herrero, F., Zornoza-Moreno, M., Pérez-Martín, J. J., Alfayate-Miguelez, S., Pérez Crespo, R., Bastida Sánchez, E., Menasalvas-Ruiz, A. I., Téllez-González, M. C., Esquiva Soto, S., Del Toro Saravia, C., Sanz-Muñoz, I., Eiros, J. M., Matías Del Pozo, V., Toquero-Asensi, M., Pastor-Villalba, E., Lluch-Rodrigo, J. A., Díez-Domingo, J., & Orrico-Sánchez, A.
Venue
Eurosurveillance
Published
2024-02-08
Volume
29
Issue
6
ISSN
  • 1025-496X (ISSN-L)
  • 1560-7917
OpenAlex
W4391683735
Cited by
194
References
2
FWCI
47.33
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024. https://app.cochat.ai/papers/10.2807/1560-7917.es.2024.29.6.2400046
The paper
López-Lacort, M., Muñoz-Quiles, C., Mira-Iglesias, A., López-Labrador, F. X., Mengual-Chuliá, B., Fernández-García, C., Carballido-Fernández, M., Pineda-Caplliure, A., Mollar-Maseres, J., Shalabi Benavent, M., Sanz-Herrero, F., Zornoza-Moreno, M., Pérez-Martín, J. J., Alfayate-Miguelez, S., Pérez Crespo, R., Bastida Sánchez, E., Menasalvas-Ruiz, A. I., Téllez-González, M. C., Esquiva Soto, S., . . . Orrico-Sánchez, A. (2024). Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024. Eurosurveillance. https://doi.org/10.2807/1560-7917.es.2024.29.6.2400046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.